Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Secondary cancers, Small cell lung cancer
Closed
Phase 3
This trial is looking at adding lurbinectedin to atezolizumab to help treat small cell lung cancer (SCLC).
It is for people whose cancer has spread within the chest or to other parts of the body. This is called extensive disease.
Recruitment start: 17 November 2021
Recruitment end: 26 December 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Raffaele Califano
Roche
Last reviewed: 2 January 2024
CRUK internal database number: 18141
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
